Nimotuzumab
Jump to navigation
Jump to search
| Nimotuzumab | |
|---|---|
| Term | Nimotuzumab |
| Short definition | Nilutamide - (pronounced) (ny-LOO-tuh-mide) drug used to treat prostate cancer that has spread to other parts of the body. It is used in patients who have had an operation (orchiectomy) on their testicles. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
nimotuzumab - (pronounced) (ny-moh-TOO-zoo-mab) substance being studied to treat some types of cancer. Nimotuzumab attaches to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. Blocking this protein can help prevent cancer cells from growing. Nimotuzumab is a type of monoclonal antibody. Also called Theraloc
External links
- Medical encyclopedia article on Nimotuzumab
- Wikipedia's article - Nimotuzumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski